E
Opko Health, Inc.
OPK
$1.90
$0.010.53%
E
Sell
3/4/2025Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 3/4/2025 due to a decline in the growth index and valuation index. Earnings per share declined from $0.0318 to $0.0176.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 3/4/2025 due to a decline in the growth index and valuation index. Earnings per share declined from $0.0318 to $0.0176.
D
Sell
3/3/2025Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 3/3/2025 due to an increase in the total return index and volatility index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 3/3/2025 due to an increase in the total return index and volatility index.
E
Sell
2/12/2025Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 2/12/2025 due to a decline in the volatility index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 2/12/2025 due to a decline in the volatility index.
D
Sell
1/23/2025Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 1/23/2025 due to an increase in the total return index and volatility index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 1/23/2025 due to an increase in the total return index and volatility index.
E
Sell
1/8/2025Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 1/8/2025 due to a decline in the volatility index and valuation index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 1/8/2025 due to a decline in the volatility index and valuation index.
D
Sell
7/18/2024Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 7/18/2024 due to an increase in the volatility index and total return index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 7/18/2024 due to an increase in the volatility index and total return index.
E
Sell
7/2/2024Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 7/2/2024 due to a decline in the volatility index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 7/2/2024 due to a decline in the volatility index.
D
Sell
6/12/2024Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 6/12/2024 due to an increase in the total return index and volatility index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 6/12/2024 due to an increase in the total return index and volatility index.
E
Sell
5/24/2024Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 5/24/2024 due to a decline in the volatility index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 5/24/2024 due to a decline in the volatility index.
D
Sell
5/9/2024Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 5/9/2024 due to an increase in the volatility index, total return index and valuation index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 5/9/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
4/29/2024Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 4/29/2024 due to a decline in the volatility index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 4/29/2024 due to a decline in the volatility index.
D
Sell
4/11/2024Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 4/11/2024 due to an increase in the volatility index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 4/11/2024 due to an increase in the volatility index.
E
Sell
3/21/2024Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 3/21/2024 due to a decline in the total return index and volatility index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 3/21/2024 due to a decline in the total return index and volatility index.
D
Sell
3/4/2024Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 3/4/2024 due to a major increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.1124 to -$0.0885, and total revenue increased 1.85% from $178.6M to $181.9M.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 3/4/2024 due to a major increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.1124 to -$0.0885, and total revenue increased 1.85% from $178.6M to $181.9M.
E
Sell
2/29/2024Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 2/29/2024 due to a decline in the volatility index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 2/29/2024 due to a decline in the volatility index.
D
Sell
2/8/2024Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 2/8/2024 due to an increase in the volatility index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 2/8/2024 due to an increase in the volatility index.
E
Sell
1/24/2024Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 1/24/2024 due to a decline in the volatility index and total return index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 1/24/2024 due to a decline in the volatility index and total return index.
D
Sell
1/4/2024Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 1/4/2024 due to an increase in the total return index and volatility index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 1/4/2024 due to an increase in the total return index and volatility index.
E
Sell
12/15/2023Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 12/15/2023 due to a decline in the volatility index and valuation index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 12/15/2023 due to a decline in the volatility index and valuation index.
D
Sell
11/24/2023Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 11/24/2023 due to an increase in the volatility index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 11/24/2023 due to an increase in the volatility index.
E
Sell
11/9/2023Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 11/9/2023 due to a decline in the growth index, solvency index and volatility index. EBIT declined 1,037.38% from $6.99M to -$65.53M, earnings per share declined from -$0.0261 to -$0.1124, and total revenue declined 32.71% from $265.42M to $178.6M.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 11/9/2023 due to a decline in the growth index, solvency index and volatility index. EBIT declined 1,037.38% from $6.99M to -$65.53M, earnings per share declined from -$0.0261 to -$0.1124, and total revenue declined 32.71% from $265.42M to $178.6M.
D
Sell
5/22/2023Upgraded
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 5/22/2023 due to an increase in the solvency index, volatility index and total return index.
Opko Health, Inc. (OPK) was upgraded to D- from E+ on 5/22/2023 due to an increase in the solvency index, volatility index and total return index.
E
Sell
5/5/2023Downgrade
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 5/5/2023 due to a decline in the volatility index.
Opko Health, Inc. (OPK) was downgraded to E+ from D- on 5/5/2023 due to a decline in the volatility index.
D
Sell
5/4/2023Downgrade
Opko Health, Inc. (OPK) was downgraded to D- from D on 5/4/2023 due to a substantial decline in the efficiency index, total return index and solvency index. Debt to equity increased from 0.16 to 0.17, and total capital declined 3.96% from $1.92B to $1.85B.
Opko Health, Inc. (OPK) was downgraded to D- from D on 5/4/2023 due to a substantial decline in the efficiency index, total return index and solvency index. Debt to equity increased from 0.16 to 0.17, and total capital declined 3.96% from $1.92B to $1.85B.
D
Sell
3/4/2022Downgrade
Opko Health, Inc. (OPK) was downgraded to D from C on 3/4/2022 due to a significant decline in the growth index, valuation index and efficiency index. EBIT declined 1,186.26% from $5.82M to -$63.23M, net income declined 356.7% from $28.74M to -$73.77M, and earnings per share declined from $0.0441 to -$0.1132.
Opko Health, Inc. (OPK) was downgraded to D from C on 3/4/2022 due to a significant decline in the growth index, valuation index and efficiency index. EBIT declined 1,186.26% from $5.82M to -$63.23M, net income declined 356.7% from $28.74M to -$73.77M, and earnings per share declined from $0.0441 to -$0.1132.
C
Hold
11/3/2021Upgraded
Opko Health, Inc. (OPK) was upgraded to C from D+ on 11/3/2021 due to a significant increase in the growth index, solvency index and efficiency index. Operating cash flow increased 316.11% from -$15.45M to $33.4M, net income increased 277.55% from -$16.19M to $28.74M, and earnings per share increased from -$0.025 to $0.0441.
Opko Health, Inc. (OPK) was upgraded to C from D+ on 11/3/2021 due to a significant increase in the growth index, solvency index and efficiency index. Operating cash flow increased 316.11% from -$15.45M to $33.4M, net income increased 277.55% from -$16.19M to $28.74M, and earnings per share increased from -$0.025 to $0.0441.
D
Sell
7/30/2021Downgrade
Opko Health, Inc. (OPK) was downgraded to D+ from C- on 7/30/2021 due to a substantial decline in the growth index, valuation index and total return index. Operating cash flow declined 159.35% from $26.04M to -$15.45M, earnings per share declined from $0.0485 to -$0.025, and EBIT declined 85.41% from $37.48M to $5.47M.
Opko Health, Inc. (OPK) was downgraded to D+ from C- on 7/30/2021 due to a substantial decline in the growth index, valuation index and total return index. Operating cash flow declined 159.35% from $26.04M to -$15.45M, earnings per share declined from $0.0485 to -$0.025, and EBIT declined 85.41% from $37.48M to $5.47M.
C
Hold
7/13/2021Downgrade
Opko Health, Inc. (OPK) was downgraded to C- from C on 7/13/2021 due to a decline in the total return index, valuation index and volatility index.
Opko Health, Inc. (OPK) was downgraded to C- from C on 7/13/2021 due to a decline in the total return index, valuation index and volatility index.
C
Hold
6/28/2021Upgraded
Opko Health, Inc. (OPK) was upgraded to C from C- on 6/28/2021 due to an increase in the volatility index and total return index.
Opko Health, Inc. (OPK) was upgraded to C from C- on 6/28/2021 due to an increase in the volatility index and total return index.
C
Hold
5/28/2021Downgrade
Opko Health, Inc. (OPK) was downgraded to C- from C on 5/28/2021 due to a decline in the volatility index and total return index.
Opko Health, Inc. (OPK) was downgraded to C- from C on 5/28/2021 due to a decline in the volatility index and total return index.
C
Hold
4/29/2021Upgraded
Opko Health, Inc. (OPK) was upgraded to C from C- on 4/29/2021 due to a significant increase in the valuation index, efficiency index and growth index. Total revenue increased 10.21% from $494.67M to $545.17M, and total capital increased 0.8% from $1.97B to $1.98B.
Opko Health, Inc. (OPK) was upgraded to C from C- on 4/29/2021 due to a significant increase in the valuation index, efficiency index and growth index. Total revenue increased 10.21% from $494.67M to $545.17M, and total capital increased 0.8% from $1.97B to $1.98B.
C
Hold
2/19/2021Upgraded
Opko Health, Inc. (OPK) was upgraded to C- from D on 2/19/2021 due to a significant increase in the efficiency index, solvency index and total return index. Net income increased 36.18% from $23.72M to $32.3M, the quick ratio increased from 0.87 to 1, and total capital increased 3.38% from $1.9B to $1.97B.
Opko Health, Inc. (OPK) was upgraded to C- from D on 2/19/2021 due to a significant increase in the efficiency index, solvency index and total return index. Net income increased 36.18% from $23.72M to $32.3M, the quick ratio increased from 0.87 to 1, and total capital increased 3.38% from $1.9B to $1.97B.
D
Sell
10/9/2020Downgrade
Opko Health, Inc. (OPK) was downgraded to D from D+ on 10/9/2020 due to a decline in the valuation index.
Opko Health, Inc. (OPK) was downgraded to D from D+ on 10/9/2020 due to a decline in the valuation index.
D
Sell
9/24/2020Upgraded
Opko Health, Inc. (OPK) was upgraded to D+ from D on 9/24/2020 due to a significant increase in the growth index, total return index and volatility index. EBIT increased 167.97% from -$41.62M to $28.29M, earnings per share increased from -$0.0923 to $0.0526, and operating cash flow increased 66.74% from -$43.37M to -$14.42M.
Opko Health, Inc. (OPK) was upgraded to D+ from D on 9/24/2020 due to a significant increase in the growth index, total return index and volatility index. EBIT increased 167.97% from -$41.62M to $28.29M, earnings per share increased from -$0.0923 to $0.0526, and operating cash flow increased 66.74% from -$43.37M to -$14.42M.
D
Sell
6/22/2020Upgraded
Opko Health, Inc. (OPK) was upgraded to D from D- on 6/22/2020 due to an increase in the total return index, growth index and volatility index.
Opko Health, Inc. (OPK) was upgraded to D from D- on 6/22/2020 due to an increase in the total return index, growth index and volatility index.
D
Sell
5/8/2020Downgrade
Opko Health, Inc. (OPK) was downgraded to D- from D on 5/8/2020 due to a large decline in the efficiency index, solvency index and valuation index. The quick ratio declined from 0.98 to 0.74, and total capital declined 3.44% from $1.93B to $1.86B.
Opko Health, Inc. (OPK) was downgraded to D- from D on 5/8/2020 due to a large decline in the efficiency index, solvency index and valuation index. The quick ratio declined from 0.98 to 0.74, and total capital declined 3.44% from $1.93B to $1.86B.
D
Sell
4/29/2020Upgraded
Opko Health, Inc. (OPK) was upgraded to D from D- on 4/29/2020 due to an increase in the total return index and volatility index.
Opko Health, Inc. (OPK) was upgraded to D from D- on 4/29/2020 due to an increase in the total return index and volatility index.
D
Sell
3/4/2020Downgrade
Opko Health, Inc. (OPK) was downgraded to D- from D on 3/4/2020 due to a major decline in the growth index, solvency index and efficiency index. Operating cash flow declined 92.9% from -$23.87M to -$46.04M, net income declined 81.19% from -$62.01M to -$112.35M, and earnings per share declined from -$0.1058 to -$0.1816.
Opko Health, Inc. (OPK) was downgraded to D- from D on 3/4/2020 due to a major decline in the growth index, solvency index and efficiency index. Operating cash flow declined 92.9% from -$23.87M to -$46.04M, net income declined 81.19% from -$62.01M to -$112.35M, and earnings per share declined from -$0.1058 to -$0.1816.
D
Sell
5/10/2018Upgraded
Opko Health, Inc. (OPK) was upgraded to D from D- on 5/10/2018 due to a large increase in the growth index and valuation index. Earnings per share increased from -$0.38 to -$0.08, EBIT increased 70.24% from -$137.28M to -$40.85M, and total revenue increased 31.6% from $193.7M to $254.91M.
Opko Health, Inc. (OPK) was upgraded to D from D- on 5/10/2018 due to a large increase in the growth index and valuation index. Earnings per share increased from -$0.38 to -$0.08, EBIT increased 70.24% from -$137.28M to -$40.85M, and total revenue increased 31.6% from $193.7M to $254.91M.
D
Sell
3/26/2018Downgrade
Opko Health, Inc. (OPK) was downgraded to D- from D on 3/26/2018 due to a substantial decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.083 to -$0.38, EBIT declined 97.51% from -$69.5M to -$137.28M, and the quick ratio declined from 1.41 to 0.92.
Opko Health, Inc. (OPK) was downgraded to D- from D on 3/26/2018 due to a substantial decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.083 to -$0.38, EBIT declined 97.51% from -$69.5M to -$137.28M, and the quick ratio declined from 1.41 to 0.92.
D
Sell
3/21/2017Downgrade
Opko Health, Inc. (OPK) was downgraded to D from D+ on 3/21/2017 due to a decline in the total return index.
Opko Health, Inc. (OPK) was downgraded to D from D+ on 3/21/2017 due to a decline in the total return index.
D
Sell
3/3/2017Upgraded
Opko Health, Inc. (OPK) was upgraded to D+ from D on 3/3/2017 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 195.02% from -$31.9M to $30.31M, and earnings per share increased from -$0.03 to -$0.0206.
Opko Health, Inc. (OPK) was upgraded to D+ from D on 3/3/2017 due to a noticeable increase in the growth index and volatility index. Operating cash flow increased 195.02% from -$31.9M to $30.31M, and earnings per share increased from -$0.03 to -$0.0206.
D
Sell
1/17/2017Downgrade
Opko Health, Inc. (OPK) was downgraded to D from D+ on 1/17/2017 due to a decline in the total return index and volatility index.
Opko Health, Inc. (OPK) was downgraded to D from D+ on 1/17/2017 due to a decline in the total return index and volatility index.
D
Sell
11/25/2016Upgraded
Opko Health, Inc. (OPK) was upgraded to D+ from D on 11/25/2016 due to an increase in the total return index and solvency index.
Opko Health, Inc. (OPK) was upgraded to D+ from D on 11/25/2016 due to an increase in the total return index and solvency index.
D
Sell
11/8/2016Downgrade
Opko Health, Inc. (OPK) was downgraded to D from D+ on 11/8/2016 due to a major decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0202 to -$0.03, net income declined 196.42% from $15.53M to -$14.98M, and operating cash flow declined 174.45% from $42.84M to -$31.9M.
Opko Health, Inc. (OPK) was downgraded to D from D+ on 11/8/2016 due to a major decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0202 to -$0.03, net income declined 196.42% from $15.53M to -$14.98M, and operating cash flow declined 174.45% from $42.84M to -$31.9M.
D
Sell
11/7/2016Downgrade
Opko Health, Inc. (OPK) was downgraded to D+ from C- on 11/7/2016 due to a decline in the volatility index.
Opko Health, Inc. (OPK) was downgraded to D+ from C- on 11/7/2016 due to a decline in the volatility index.
C
Hold
8/10/2016Upgraded
Opko Health, Inc. (OPK) was upgraded to C- from D+ on 8/10/2016 due to a large increase in the growth index, valuation index and efficiency index. Operating cash flow increased 565.37% from -$9.21M to $42.84M, EBIT increased 555.62% from -$8.57M to $39.02M, and net income increased 229.68% from -$11.98M to $15.53M.
Opko Health, Inc. (OPK) was upgraded to C- from D+ on 8/10/2016 due to a large increase in the growth index, valuation index and efficiency index. Operating cash flow increased 565.37% from -$9.21M to $42.84M, EBIT increased 555.62% from -$8.57M to $39.02M, and net income increased 229.68% from -$11.98M to $15.53M.
D
Sell
5/12/2016Upgraded
Opko Health, Inc. (OPK) was upgraded to D+ from D on 5/12/2016 due to a noticeable increase in the efficiency index, valuation index and growth index. EBIT increased 8.44% from -$9.36M to -$8.57M, total revenue increased 5.38% from $276.19M to $291.04M, and operating cash flow increased 1.55% from -$9.35M to -$9.21M.
Opko Health, Inc. (OPK) was upgraded to D+ from D on 5/12/2016 due to a noticeable increase in the efficiency index, valuation index and growth index. EBIT increased 8.44% from -$9.36M to -$8.57M, total revenue increased 5.38% from $276.19M to $291.04M, and operating cash flow increased 1.55% from -$9.35M to -$9.21M.
D
Sell
3/11/2016Downgrade
Opko Health, Inc. (OPK) was downgraded to D from D+ on 3/11/2016 due to a noticeable decline in the volatility index and total return index.
Opko Health, Inc. (OPK) was downgraded to D from D+ on 3/11/2016 due to a noticeable decline in the volatility index and total return index.
D
Sell
3/4/2016Downgrade
Opko Health, Inc. (OPK) was downgraded to D+ from C- on 3/4/2016 due to a major decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.2509 to $0.003, net income declined 98.75% from $128.25M to $1.6M, and operating cash flow declined 70.18% from -$31.36M to -$9.35M.
Opko Health, Inc. (OPK) was downgraded to D+ from C- on 3/4/2016 due to a major decline in the growth index, total return index and efficiency index. Earnings per share declined from $0.2509 to $0.003, net income declined 98.75% from $128.25M to $1.6M, and operating cash flow declined 70.18% from -$31.36M to -$9.35M.
C
Hold
11/30/2015Downgrade
Opko Health, Inc. (OPK) was downgraded to C- from C on 11/30/2015 due to a decline in the solvency index, volatility index and total return index.
Opko Health, Inc. (OPK) was downgraded to C- from C on 11/30/2015 due to a decline in the solvency index, volatility index and total return index.
C
Hold
11/13/2015Upgraded
Opko Health, Inc. (OPK) was upgraded to C from C- on 11/13/2015 due to a major increase in the growth index, efficiency index and solvency index. Total revenue increased 237.11% from $42.43M to $143.03M, total capital increased 121.92% from $952.94M to $2.11B, and debt to equity declined from 0.15 to 0.07.
Opko Health, Inc. (OPK) was upgraded to C from C- on 11/13/2015 due to a major increase in the growth index, efficiency index and solvency index. Total revenue increased 237.11% from $42.43M to $143.03M, total capital increased 121.92% from $952.94M to $2.11B, and debt to equity declined from 0.15 to 0.07.
C
Hold
8/7/2015Downgrade
Opko Health, Inc. (OPK) was downgraded to C- from C on 8/7/2015 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 2.02 to 1.38.
Opko Health, Inc. (OPK) was downgraded to C- from C on 8/7/2015 due to a decline in the total return index, volatility index and solvency index. The quick ratio declined from 2.02 to 1.38.
C
Hold
7/10/2015Upgraded
Opko Health, Inc. (OPK) was upgraded to C from C- on 7/10/2015 due to an increase in the total return index.
Opko Health, Inc. (OPK) was upgraded to C from C- on 7/10/2015 due to an increase in the total return index.
C
Hold
6/22/2015Downgrade
Opko Health, Inc. (OPK) was downgraded to C- from C on 6/22/2015 due to a noticeable decline in the growth index, volatility index and efficiency index. Operating cash flow declined 1,064.39% from -$24.76M to $238.79M, EBIT declined 14.08% from -$30.09M to -$25.85M, and total capital declined 4.89% from $983.08M to $935.03M.
Opko Health, Inc. (OPK) was downgraded to C- from C on 6/22/2015 due to a noticeable decline in the growth index, volatility index and efficiency index. Operating cash flow declined 1,064.39% from -$24.76M to $238.79M, EBIT declined 14.08% from -$30.09M to -$25.85M, and total capital declined 4.89% from $983.08M to $935.03M.
C
Hold
3/2/2015Upgraded
Opko Health, Inc. (OPK) was upgraded to C from C- on 3/2/2015 due to a major increase in the total return index, growth index and valuation index. Total revenue increased 29.13% from $19.77M to $25.53M, operating cash flow increased 17.48% from -$21.08M to -$24.76M, and earnings per share increased from -$0.1138 to -$0.1199.
Opko Health, Inc. (OPK) was upgraded to C from C- on 3/2/2015 due to a major increase in the total return index, growth index and valuation index. Total revenue increased 29.13% from $19.77M to $25.53M, operating cash flow increased 17.48% from -$21.08M to -$24.76M, and earnings per share increased from -$0.1138 to -$0.1199.
C
Hold
2/13/2015Upgraded
Opko Health, Inc. (OPK) was upgraded to C- from D+ on 2/13/2015 due to a major increase in the volatility index, total return index and solvency index.
Opko Health, Inc. (OPK) was upgraded to C- from D+ on 2/13/2015 due to a major increase in the volatility index, total return index and solvency index.
D
Sell
11/10/2014Downgrade
Opko Health, Inc. (OPK) was downgraded to D+ from C- on 11/10/2014 due to a substantial decline in the total return index, growth index and volatility index. Total revenue declined 16.02% from $23.55M to $19.77M.
Opko Health, Inc. (OPK) was downgraded to D+ from C- on 11/10/2014 due to a substantial decline in the total return index, growth index and volatility index. Total revenue declined 16.02% from $23.55M to $19.77M.
NASDAQ
03/07/2025 4:00PM Eastern
Quotes delayed
